Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,600 across all filing types
Latest filing 2024-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
113年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the year 2024 (民國113年第1季), with detailed financial data including operating, investing, and financing cash flows. The presence of actual financial figures for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2191 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2024-05-14 Chinese
113年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the 113th year (which corresponds to 2024) with detailed financial figures such as revenue, costs, expenses, net profit, and earnings per share. The presence of actual financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2238 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2024-05-14 Chinese
113年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is for the first quarter of the year 113 (Taiwan calendar, corresponding to 2024). The document length is 3824 characters, which is relatively short but contains substantive financial data, not just an announcement or a link to a report. The presence of detailed financial statements for a quarterly period indicates this is an Interim / Quarterly Report rather than a brief announcement or a full annual report. There is no indication that this is a certification, proxy, or other type of filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2024-05-14 Chinese
113年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (杏輝) providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (624 characters) and appears to be a regulatory disclosure rather than a full financial report. There is no indication of a full annual or interim report, audit report, or earnings release. The content fits the profile of a regulatory announcement or compliance filing related to financial guarantees and loans. Given the short length and nature of the data, it is best classified as a Regulatory Filing (RNS).
2024-05-10 Chinese
113年4月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month (April 2024) and compares it to the previous year. The document length is short (768 characters) but it includes substantive financial data, not just an announcement or a link to a report. It is not a full annual or interim report but rather a periodic financial summary. Given the presence of actual financial figures and the nature of the data, this fits best as an Interim / Quarterly Report (IR).
2024-05-10 Chinese
113年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, chairpersons, general managers, and their family members. It shows changes in shareholdings, including increases and decreases, and categorizes shares by type and ownership status. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or regulatory announcement about voting or dividends. The document is a report of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification, so it is not RNS or RPA.
2024-05-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.